All In Biotech

Free tool

FAERS Monitor: Velphoro

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205109 or its brand name (Velphoro, Ferric Oxyhydroxide). Reports on generic versions are filed under their own applications.

Reports

3,046

Serious

2,193

72% of reports

Hospitalization

556

Death reported

1,293

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death1,146
  • diarrhoea328
  • nausea100
  • constipation90
  • hospitalisation88
  • vomiting87
  • faeces discoloured84
  • drug intolerance68
  • abdominal discomfort63
  • off label use61
  • product taste abnormal60
  • abdominal pain53
  • end stage renal disease52
  • chronic kidney disease50
  • pruritus47

Reports by year received

View as table
YearReports
201425
2015131
2016135
2017259
2018284
2019479
2020661
2021320
2022114
2023105
2024195
2025216
2026122

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,113 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product taste abnormalSignal6030.723.91,690
faeces discolouredSignal8426.921.72,060
end stage renal diseaseSignal5219.715.1905
deathSignal1,1469.28.88,709
drug intoleranceSignal684.93.8206
chronic kidney diseaseSignal504.53.5135
hospitalisationSignal884.03.2193
diarrhoeaSignal3283.53.2604
constipationSignal902.92.3107
abdominal discomfortSignal632.62.061
abdominal pain531.61.211
vomiting871.31.05
nausea1000.90.72
pruritus470.80.61
off label use610.50.435

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.